A network of hospitals in the UK have implemented a chemotherapy software solution that enables patients to become more involved in managing their own care.
24/02/2010 |
A new stent graft can open vessels that become blocked or narrowed at the point where dialysis machines connect to the body. The stent has received approval from the US Food and Drug Administration.
16/02/2010 |
A US biotech company, EDP Biotech (EDP), has developed a new technology for detecting early-stage colon cancer. EDP says the blood test is inexpensive and can detect colon cancer in its earliest, most curable stages.
16/02/2010 |
Roche is investing about 190 million Swiss Francs (approx. AUD$210 million) in a new technology that might allow breast cancer patients to self-administer cancer drugs such as Herceptin.
29/01/2010 |
Royal North Shore Hospital in Sydney has become the first hospital in Australia to be formally accredited by Varian Medical Systems as a teaching facility for image-guided radiotherapy (IGRT).
28/01/2010 |
Some Queensland residents suffering from chronic disease will be the first to trial a new chronic care program that aims to improve the quality of life and reduce the rate of unplanned hospital admissions for patients with heart disease, Type 2 diabetes and other long-term chronic illnesses.
28/01/2010 |
Roche has announced results from studies showing that Herceptin reduces the risk of the cancer returning by about one third in women with HER2-positive early breast cancer compared to patients receiving chemotherapy alone.
17/12/2009 |
The Translational Genomics Research Institute (TGen) and Scottsdale Healthcare are testing a new drug, PHA-848125AC, specifically for thymic cancer based on early promising results at Scottsdale Healthcare.
17/12/2009 |
The Queensland Paediatric Cardiac Service (QPCS) at Mater Children’s Hospital has registered Australia’s first paediatric cardiac patient in a remote monitoring system that allows patients with implanted cardiac devices to be examined over the internet.
15/12/2009 |
CSIRO is using the latest in computer gaming technology to help reduce the incidence of bowel cancer by training gastroenterologists to use a colonoscopy simulator.
14/12/2009 |
Roche has announced that its Phase III clinical trial evaluation of ocrelizumab as a treatment for seropositive rheumatoid arthritis (RA) patients with a previous inadequate response to methotrexate (MTX), has met its primary efficacy endpoint.
14/12/2009 |
HIV-positive adults are being recruited to participate in a clinical trial of the 2009 H1N1 influenza vaccine. The US study will involve 240 men and women of 18 - 64 years of age.
14/12/2009 |
US researchers report that the 2009 H1N1 Influenza virus can damage cells throughout the respiratory airway, as discovered from autopsies of fatal cases. The damage seen is much like that of earlier influenza pandemics in 1918 and 1957.
11/12/2009 |
The Therapeutic Goods Administration (TGA) has advised on some of the adverse reactions following vaccination with Gardasil, a vaccine against human papilloma virus (HPV).
11/12/2009 |
US researchers have found that injections of the drug rituximab slows down beta cell destruction in the pancreas of patients newly diagnosed with type 1 diabetes for at least a year. The findings suggest a potential treatment option that might improve management and reduce long-term complications of the disease.
10/12/2009 |
The National Institute of Allergy and Infectious Diseases (NIAID) is conducting a clinical trial to compare immune responses of healthy pregnant and non-pregnant women to an inactivated 2009 H1N1 influenza vaccine.
08/12/2009 |
Screening and surveillance guidelines for the for the early detection of colorectal cancer and adenomatous polyps have been released by the US Agency for Healthcare Research and Quality (AHRQ).
08/12/2009 |
The American Congress of Obstetricians and Gynecologists (ACOG) recommend that women can be screened less frequently for cervical cancer with the Pap test (cervical cytology) than previously recommended.
04/12/2009 |
A patient attending the Delaware Valley Urology Cancer Center has experienced the difference in length of radiotherapy treatment sessions from 20min down to less than five, since the hospital acquired RapidArc radiotherapy technology from Varian Medical Systems.
04/12/2009 |
The Therapeutic Goods Administration (TGA) has approved for registration the Australian-made Panvax H1N1 Vaccine Junior enabling children from 6 months to 9 years of age to be protected against the pandemic H1N1 influenza.
04/12/2009 |